Nothing Special   »   [go: up one dir, main page]

Long et al., 2023 - Google Patents

Reoperation and pain-related outcomes after hysterectomy for endometriosis by oophorectomy status

Long et al., 2023

Document ID
1627882020166732531
Author
Long A
Kaur P
Lukey A
Allaire C
Kwon J
Talhouk A
Yong P
Hanley G
Publication year
Publication venue
American Journal of Obstetrics and Gynecology

External Links

Snippet

Background More research is needed that compares the outcomes between those who underwent a hysterectomy for endometriosis with conservation of one or both ovaries and those who underwent a hysterectomy with bilateral salpingo-oophorectomy. Objective This …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

Similar Documents

Publication Publication Date Title
Wouk et al. Abnormal uterine bleeding in premenopausal women
Rodriguez et al. Progestogen‐releasing intrauterine systems for heavy menstrual bleeding
Rodriguez et al. Interventions for heavy menstrual bleeding; overview of Cochrane reviews and network meta‐analysis
Marret et al. Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause
Armstrong et al. Diagnosis and management of endometrial hyperplasia
Gallos et al. Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis
Rizk et al. Recurrence of endometriosis after hysterectomy
Lang et al. Dienogest for treatment of endometriosis in Chinese women: a placebo-controlled, randomized, double-blind phase 3 study
Missmer et al. In utero exposures and the incidence of endometriosis
Gustofson et al. Endometriosis and the appendix: a case series and comprehensive review of the literature
Shim et al. Dysmenorrhea and endometriosis in transgender adolescents
Oguz et al. The role of hormone replacement therapy in endometrial polyp formation
Grimstad et al. Breakthrough bleeding in transgender and gender diverse adolescents and young adults on long-term testosterone
Bakas et al. Hysteroscopic resection of uterine septum and reproductive outcome in women with unexplained infertility
Long et al. Reoperation and pain-related outcomes after hysterectomy for endometriosis by oophorectomy status
Brucker et al. Clinical characteristics indicating adenomyosis coexisting with leiomyomas: a retrospective, questionnaire-based study
Baker et al. Nonoperative management of atypical endometrial hyperplasia and grade 1 endometrial cancer with the levonorgestrel intrauterine device in medically ill post-menopausal women
Merrill et al. Risk estimates of hysterectomy and selected conditions commonly treated with hysterectomy
Lucchini et al. Updates on conservative management of endometrial cancer in patients younger than 45 years
Matorras et al. Endometriosis and spontaneous abortion rate: a cohort study in infertile women
Dason et al. Guideline No. 437: diagnosis and management of adenomyosis
Marschalek et al. Anatomic outcomes after pelvic-organ-prolapse surgery—comparing uterine preservation with hysterectomy
Health Quality Ontario Levonorgestrel-releasing intrauterine system (52 mg) for idiopathic heavy menstrual bleeding: a health technology assessment
Gelderblom et al. The effect of opportunistic salpingectomy for primary prevention of ovarian cancer on ovarian reserve: a systematic review and meta-analysis
Elford et al. Novel treatment of a patient with secondary infertility due to retained fetal bone